Healthcare and Tech Lead SP 500 to Modest Gains Communication Services Lags WWEs Saturday Nights Main Event 2026 Preview Potential Content Catalyst for TKO Group Holdings Three African Oil Giants Poised to Benefit From Prolonged Hormuz Strait Disruptions Analysts Suggest US Consumer Sentiment Sinks to Record Low in May as Iran Conflict Fuels Inflation Fears US Consumer Sentiment Remains Subdued Amid Inflation Geopolitical Tensions and Trade Policy Uncertainty Fox Corporation Shares Dip in Q1 After Strong Prior Run Braemar Hotels Resorts BHR Q1 2026 Earnings Stunning EPS Surprise of 42178 on a Loss Estimate ZTEK Q3 2023 Earnings Narrow Loss Beat Estimates as Stock Declines PRAX Q1 2026 Earnings Narrowerthanexpected loss as Praxis Precision Medicines advances pipeline Neuropace Inc NPCE Q1 2026 Earnings Narrower Loss Exceeds Expectations Stock Rises AKBA Q1 2026 Earnings Slight EPS Miss Amid Continued Operational Progress ATS Q1 2026 Earnings EPS Beats Estimates by 924 Stock Rises 184 USLM Holds Steady Near 106 United States Lime Minerals Consolidates in Tight Range AGNCN Preferred Stock Holds Steady Near 2578 as Support and Resistance Levels Define Trading Range DSYWW Warrants Hold Steady at 002 Amid Minimal Trading Activity Aclarion Inc ACON Edges Higher as Stock Tests Resistance Near 331 Gold Fields GFI Gains 263 as Bullish Momentum Builds CurtissWright Corp CW Poised for Strategic Advantage Amid Geopolitical Uncertainty IINN Q4 2023 Earnings Narrower Loss Surprises as Inspira Advances Clinical Milestones Avalo Therapeutics AVTX Slips 15 as Stock Consolidates Between Key Support and Resistance Marine Products Corporation MPX Edges Lower Amidst RangeBound Trading Novavax NVAX Edges Higher Amid Vaccine Sector Focus Key Levels to Watch Universal Logistics Holdings ULH Posts 194 Gain Approaches Resistance at 1710 Bolt Biotherapeutics BOLT Gains 232 Biotech Stock Approaches Key Resistance Level Equinix EQIX Holds Steady Near Key Resistance as Data Center Demand Remains Strong GBAB Edges Higher Navigating Yield and Resistance in a Taxable Municipal Bond CEF NervGen Pharma NGEN Dips 282 to 207 Approaching Key Support